Literature DB >> 27942956

Building on evidence to improve patient care.

Evelien Snauwaert1, Johan VandeWalle1, Evi V Nagler2,3, Wim Van Biesen4,5.   

Abstract

Evidence-based medicine (EBM) is gaining importance in the current paediatric healthcare landscape. Improvement of paediatric health status is its major aim. However, for EBM to be successful, all stakeholders involved should understand what EBM really is, why and how EBM should or should not be practiced, and have the necessary skills to distinguish methodologically sound papers from biased opinion papers, and understand how and why guidelines are different from systematic reviews. Improving patient outcome requires attention to high-quality evidence and understanding of the processes of medical decision-making. Rigorous methodology is the cornerstone of guideline production, but in cases where quality evidence cannot be produced, as is often the case in paediatric nephrology because of low patient numbers, consensus-based guidance may be suitable to assist the practitioner at the bedside, as long as the underlying process is transparent. Most importantly, EBM should support patient involvement in a shared decision-making process. The more consistent and accurately predictable the effect of certain interventions is, clinically relevant to patients rather than affecting surrogate outcomes, and a priority for patients and other stakeholders, the more likely it is that adherence to the guidance provided will improve the outcome of patients.

Entities:  

Keywords:  Evidence based medicine; Guideline; Health economy; Paediatric; Shared decision making; Sustainable treatment

Mesh:

Year:  2016        PMID: 27942956     DOI: 10.1007/s00467-016-3554-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  34 in total

1.  GRADE guidelines: 3. Rating the quality of evidence.

Authors:  Howard Balshem; Mark Helfand; Holger J Schünemann; Andrew D Oxman; Regina Kunz; Jan Brozek; Gunn E Vist; Yngve Falck-Ytter; Joerg Meerpohl; Susan Norris; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

Review 2.  The valuable contribution of observational studies to nephrology.

Authors:  K J Jager; V S Stel; C Wanner; C Zoccali; F W Dekker
Journal:  Kidney Int       Date:  2007-06-27       Impact factor: 10.612

3.  Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines.

Authors:  Sabine N van der Veer; Charles R V Tomson; Kitty J Jager; Wim van Biesen
Journal:  Nephrol Dial Transplant       Date:  2013-12-17       Impact factor: 5.992

4.  Systematic reviews and their roles in promoting evidence-based medicine in renal disease.

Authors:  D Fouque; M Laville; M Haugh; J P Boissel
Journal:  Nephrol Dial Transplant       Date:  1996-12       Impact factor: 5.992

5.  Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement.

Authors:  David Goldsmith; Adrian Covic; Marc Vervloet; Mario Cozzolino; Ionut Nistor
Journal:  Nephrol Dial Transplant       Date:  2015-03-04       Impact factor: 5.992

6.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

7.  Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  K Uhlig; A Macleod; J Craig; J Lau; A S Levey; A Levin; L Moist; E Steinberg; R Walker; C Wanner; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2006-09-27       Impact factor: 10.612

8.  Differing levels of clinical evidence: exploring communication challenges in shared decision making. Introduction.

Authors:  Quentin W Smith; Richard L Street; Robert J Volk; Michael Fordis
Journal:  Med Care Res Rev       Date:  2012-12-06       Impact factor: 3.929

9.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

10.  Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.

Authors:  Allison Tong; Braden Manns; Brenda Hemmelgarn; David C Wheeler; Peter Tugwell; Wolfgang C Winkelmayer; Wim van Biesen; Sally Crowe; Peter G Kerr; Kevan R Polkinghorne; Kirsten Howard; Carol Pollock; Carmel M Hawley; David W Johnson; Stephen P McDonald; Martin P Gallagher; Rachel Urquhart-Secord; Jonathan C Craig
Journal:  Trials       Date:  2015-08-19       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.